|
Learning objectives
|
Summer 2011
|
Summer 2012
|
|---|
|
Initial performance level
|
Thentest rating
|
Posttest rating
|
|---|
|
True pretest (n = 83)
|
Thentest (n = 83)
|
Group A: sequential (n = 42)
|
Group B: direct (n = 32)
|
Group A: sequential (n = 42)
|
Group B: direct (n = 32)
|
|---|
|
Acute bronchitis
|
4.35 ± 1.31
|
4.75 ± 1.24
|
5.00 ± 0.99
|
4.56 ± 1.13
|
3.21 ± 1.46
|
3.09 ± 1.06
|
|
Pericarditis
|
5.90 ± 0.30
|
5.51 ± 1.13
|
5.50 ± 1.11
|
5.50 ± 1.27
|
2.74 ± 1.48
|
2.34 ± 1.45
|
|
Acute arterial occlusion
|
3.82 ± 1.46
|
4.13 ± 1.40
|
4.10 ± 1.30
|
4.53 ± 1.32
|
1.74 ± 1.31
|
1.69 ± 0.93
|
|
Acute myocardial infarction
|
3.14 ± 1.41
|
3.63 ± 1.62
|
3.93 ± 1.40
|
4.41 ± 1.37
|
1.36 ± 0.53
|
1.63 ± 1.04
|
|
Aortic aneurysm & dissection
|
5.19 ± 1.38
|
4.91 ± 1.53
|
5.40 ± 1.17
|
5.38 ± 1.21
|
1.55 ± 0.77
|
1.47 ± 1.05
|
|
Aortic stenosis
|
4.58 ± 1.35
|
4.94 ± 1.36
|
5.22 ± 1.15
|
5.19 ± 1.15
|
1.74 ± 0.99
|
2.00 ± 1.08
|
|
Asthma
|
5.14 ± 1.10
|
5.31 ± 1.13
|
5.02 ± 1.33
|
5.34 ± 1.34
|
2.05 ± 1.13
|
2.13 ± 0.98
|
|
Atherosclerosis
|
2.94 ± 1.38
|
3.39 ± 1.38
|
3.32 ± 1.29
|
3.84 ± 1.51
|
1.79 ± 0.81
|
1.94 ± 1.22
|
|
Chronic bronchitis
|
4.28 ± 1.48
|
4.66 ± 1.37
|
4.56 ± 1.34
|
4.78 ± 1.29
|
2.29 ± 1.18
|
2.03 ± 1.09
|
|
COPD
|
5.42 ± 0.80
|
5.34 ± 1.23
|
5.29 ± 1.10
|
5.34 ± 1.31
|
1.60 ± 0.94
|
1.94 ± 1.01
|
|
Pulmonary emphysema
|
5.42 ± 0.68
|
5.48 ± 1.02
|
5.29 ± 1.03
|
5.19 ± 1.42
|
2.64 ± 1.48
|
2.31 ± 1.23
|
|
Endocarditis
|
5.55 ± 0.97
|
5.52 ± 1.17
|
5.51 ± 1.31
|
5.66 ± 1.13
|
2.02 ± 1.39
|
1.91 ± 1.15
|
|
Tetralogy of Fallot
|
5.18 ± 1.33
|
5.01 ± 1.61
|
5.12 ± 1.74
|
5.38 ± 1.52
|
1.57 ± 1.35
|
1.41 ± 1.23
|
|
Congestive heart failure
|
4.59 ± 1.31
|
5.07 ± 1.34
|
4.76 ± 1.48
|
5.41 ± 1.24
|
1.64 ± 0.79
|
1.59 ± 1.10
|
|
Arterial hypertension
|
3.58 ± 1.42
|
4.56 ± 1.21
|
4.44 ± 1.48
|
4.69 ± 1.33
|
3.14 ± 1.49
|
2.34 ± 1.23
|
|
Influenza
|
2.87 ± 1.44
|
3.81 ± 1.40
|
4.27 ± 1.58
|
4.59 ± 1.48
|
2.48 ± 1.35
|
2.47 ± 1.22
|
|
Cardiomyopathy
|
5.73 ± 0.59
|
5.55 ± 0.93
|
5.50 ± 1.18
|
5.59 ± 1.16
|
2.64 ± 1.21
|
2.53 ± 1.11
|
|
Coronary artery disease
|
2.93 ± 1.53
|
3.23 ± 1.32
|
2.85 ± 1.30
|
3.63 ± 1.58
|
1.21 ± 0.47
|
1.31 ± 1.00
|
|
Pulmonary embolism
|
5.67 ± 0.61
|
5.68 ± 0.83
|
5.37 ± 0.99
|
5.22 ± 1.39
|
2.45 ± 1.15
|
2.41 ± 1.16
|
|
Mitral regurgitation
|
4.69 ± 1.22
|
4.99 ± 1.26
|
4.90 ± 1.15
|
5.28 ± 1.05
|
2.07 ± 0.89
|
2.25 ± 1.02
|
|
Myocarditis
|
4.96 ± 1.13
|
5.28 ± 1.03
|
5.15 ± 1.26
|
5.44 ± 1.16
|
2.38 ± 1.06
|
2.31 ± 0.93
|
|
Peripheral artery disease
|
4.95 ± 1.38
|
5.21 ± 1.28
|
4.83 ± 1.47
|
4.88 ± 1.54
|
2.17 ± 1.31
|
2.47 ± 1.61
|
|
Patent foramen ovale
|
5.45 ± 0.94
|
5.45 ± 1.06
|
5.46 ± 1.00
|
5.66 ± 1.13
|
2.90 ± 1.59
|
2.69 ± 1.53
|
|
Pleural effusion
|
5.32 ± 0.89
|
5.33 ± 1.02
|
5.07 ± 1.37
|
5.41 ± 1.16
|
2.69 ± 1.28
|
2.91 ± 1.25
|
|
Pneumonia
|
4.59 ± 1.43
|
4.85 ± 1.30
|
4.98 ± 1.29
|
5.31 ± 1.12
|
2.31 ± 1.35
|
2.41 ± 1.39
|
|
Pneumothorax
|
3.48 ± 1.36
|
3.99 ± 1.37
|
4.32 ± 1.46
|
4.59 ± 1.39
|
2.33 ± 1.20
|
2.19 ± 1.15
|
|
Pulmonary hypertension
|
4.49 ± 1.37
|
5.30 ± 1.01
|
5.10 ± 1.18
|
5.22 ± 1.39
|
3.36 ± 1.64
|
3.28 ± 1.33
|
|
Interstitial lung disease
|
5.60 ± 0.87
|
5.74 ± 0.70
|
5.69 ± 0.72
|
5.66 ± 1.04
|
3.98 ± 1.56
|
4.69 ± 1.31
|
|
Cardiac arrhythmias
|
4.25 ± 1.61
|
4.88 ± 1.48
|
5.19 ± 1.19
|
5.31 ± 1.38
|
2.05 ± 1.04
|
2.16 ± 1.44
|
|
Cardiogenic shock
|
4.55 ± 1.20
|
4.76 ± 1.23
|
4.76 ± 1.19
|
4.97 ± 1.20
|
3.00 ± 1.23
|
2.88 ± 1.19
|
|
Rheumatic fever
|
5.00 ± 1.13
|
5.51 ± 0.98
|
5.50 ± 0.99
|
5.50 ± 0.95
|
3.02 ± 1.41
|
2.91 ± 1.15
|
|
Smoking
|
5.63 ± 0.71
|
5.37 ± 1.34
|
5.43 ± 1.25
|
5.50 ± 1.30
|
1.86 ± 1.46
|
2.31 ± 1.66
|
|
Tuberculosis
|
5.40 ± 0.84
|
5.49 ± 0.88
|
5.14 ± 1.20
|
5.34 ± 1.21
|
3.45 ± 1.66
|
3.44 ± 1.50
|
- Data are presented as means ± standard deviations. COPD, chronic obstructive pulmonary disease.
